体内
化学
药理学
药品
药物发现
计算生物学
毒理
生物化学
医学
生物
生物技术
作者
Travis T. Wager,Bethany L. Kormos,Joseph T. Brady,Yvonne Will,Michael D. Aleo,Donald B. Stedman,Max Kühn,Ramalakshmi Y. Chandrasekaran
摘要
A set of molecules that advanced into exploratory animal toxicology studies (two species) was examined to determine what properties contributed to success in these safety studies. Compounds were rigorously evaluated across numerous safety end points and classified as “pass” if a suitable in vivo therapeutic index (TI) was achieved for advancement into regulatory toxicology studies. The most predictive end point contributing to compound survival was a predicted human efficacious concentration (Ceff) of ≤250 nM (total drug) and ≤40 nM (free drug). This trend held across a wide range of CNS modes of action, encompassing targets such as enzymes, G-protein-coupled receptors, ion channels, and transporters.
科研通智能强力驱动
Strongly Powered by AbleSci AI